4-methyl-1-[5-(2-methylsulfonylphenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]piperidin-4-amine
C18H22N6O2S2 — CID 155796519
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-methyl-1-[5-(2-methylsulfonylphenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]piperidin-4-amine
4-methyl-1-[5-(2-methylsulfonylphenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]piperidin-4-amine (PubChem CID 155796519) has the molecular formula C18H22N6O2S2 and a molecular weight of 418.55 g/mol. Its IUPAC name is 4-methyl-1-[5-(2-methylsulfonylphenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]piperidin-4-amine.
Molecular Properties
| Compound Name | 4-methyl-1-[5-(2-methylsulfonylphenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]piperidin-4-amine |
|---|---|
| PubChem CID | 155796519 |
| Molecular Formula | C18H22N6O2S2 |
| Molecular Weight | 418.55 g/mol |
| Exact Mass | 418.12 |
| IUPAC Name | 4-methyl-1-[5-(2-methylsulfonylphenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]piperidin-4-amine |
| SMILES | CC1(N)CCN(c2nc3ncc(Sc4ccccc4S(C)(=O)=O)nc3[nH]2)CC1 |
| InChI | InChI=1S/C18H22N6O2S2/c1-18(19)7-9-24(10-8-18)17-22-15-16(23-17)21-14(11-20-15)27-12-5-3-4-6-13(12)28(2,25)26/h3-6,11H,7-10,19H2,1-2H3,(H,20,21,22,23) |
| InChIKey | ACISTAMTQOEKKL-UHFFFAOYSA-N |
| XLogP | 2.23 |
| TPSA | 117.86 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 418.55 |
| LogP ≤ 5 | 2.23 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155796519 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.